Followers | 240 |
Posts | 12051 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |
Tuesday, August 04, 2015 10:01:42 AM
USA Equities Corp., a Delaware corporation f/k/a American Biogenetic Sciences, Inc. through its newly organized Delaware subsidiary, USA Equities Trust, Inc., completed an Asset Purchase Agreement with an unaffiliated third party, Green US Builders, Inc., a Delaware corporation for the purchase of a commercial building located at 1191-1209 East Main Street, Bridgeport, CT. The acquisition of the Property is in furtherance of the company's business plan of acquiring income producing real estate and becoming an operating company.
The CFO, director and principal stockholder, Troy Grogan, exercised a portion of his convertible note in the aggregate principal amount of $76,000 in consideration for the issuance of 2,500,000 restricted shares of the common stock, par value $0.0001 per share in the name of Trojan Holdings Company, LLC, a Florida limited liability company, at the conversion price set forth in the Convertible Note of $0.001. On 8/03/15, the company authorized the issuance of 2,400,000 restricted shares in the name of Funding Equities, Inc., a Florida corporation, as designee of the Seller.
http://www.sec.gov/Archives/edgar/data/856984/000129534515000191/maba08032015.htm
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent USAQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:30:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 02:33:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:22:47 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM